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Cyclosporine Measurement by Fluorescent Polarization Immunoassay 
Utilizing Abbott TDx· Instrument 
Ajit Sanghvi, Warren F. Diven, Vijay S. Warty, and Thomas Starzl 
WE HAVE evaluated the usefulness of a fluorescent polarization immunoassay (FPIA) utilizing the 
Abbott TD.· technology for the routine measurements of 
cyclosporine in whole blood or plasma. This procedure was 
compared with the Sandoz radioimmunoassay. The evalua-
tion was undertaken in an effort to decrease the radioactive 
hazard, and contain the reagent and supply costs, as well as 
to reduce the cost of the highly trained labor component 
associated with an RIA procedure. Specimens from liver, 
heart, heart/lung, and kidney transplant patients were ana-
lyzed, and statistical correlations were obtained. These data 
indicate that the FPIA assay compares favorably with the 
Sandoz RIA procedure and provides a reliable method for 
determining cyclosporine. The advantages of this procedure 
are that it is relatively much simpler and that it represents a 
less hazardous technology. Perhaps more importantly even, 
the FPIA assay, coupled with the use of Abbott TD.· 
instrumentation, allows us to report the cyclosporine results 
in a much shorter time. Preliminary experiments with this 
assay suggest that it may be crossreacting with metabolites 
more extensively or measuring a greater number of them 
relative to RIA. 
Cyclosporine has become the immunosuppressive agent of 
choice in organ transplantation and frequent monitoring of 
drug levels in blood or plasma has proven to be a contributing 
factor to the success of transplantation. We have evaluated 
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Fig. 1. 
Abbott Laboratories' whole blood method for measuring 
cyclosporine using a TD,- instrument and fluorescent polari-
zation immunoassay (FPIA). Like other immunoassays for 
cyclosporine the FPIA antibody reacts with both the parent 
drug and its metabolites. Although the identity of each 
specific metabolite and its relative reactivity is not known, 
early studies indicate that crossreactivity may be greater 
with the FPIA antibody when compared to the Sandoz RIA 
method. 
MATERIALS AND METHODS 
Samples were collected from kidney, heart, heart/lung, and liver 
transplant patients in tubes containing EDT A anticoagulant. Both 
RIA and FPIA were performed according to the manufacturer's 
instructions. HPLC assay was carried out by the procedure in 
routine use in our laboratory. Patients were followed throughout the 
course of immunosuppressive therapy immediately following trans-
plant. 
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CYCLOSPORINE MEASUREMENT 
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RESULTS 
Figure 1 presents the FPIA-RIA comparison for all speci-
mens analyzed. The correlation coefficient for these data is 
0.935, and the regression equation is FPIA value = 
(1.38)(RIA value) + 4. 
Figures 2-4 present the FPIA-RIA comparisons according 
to the organ transplanted. 
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Figures 5-7 present the trend analysis of typical individual 
kidney, heart and liver patients. 
CONCLUSIONS 
Although there is a good correlation between the RIA and 
FPIA assays, the FPIA values are consistently higher (1.4 
times liver and heart, 1.3 times kidney). These data would 
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suggest that the FPIA antibody is more highly cross reactive 
to metabolites or sensitive to metabolites not measured by 
RIA. 
Studies on individual patients show that FPIA and RIA 
values follow a similar course, with FPIA values consistently 
greater that those obtained using RIA. Both immunoassays 
display cyclosporine values higher than those obtained by 
HPLC analysis, which measures only the parent drug. 
